• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Thursday, May 8
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025

    Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

    May 7, 2025

    ‘Wait Them Out’: John Kennedy Tells Larry Kudlow One Lie He Suspects China’s Telling US

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Health»Hims & Hers’ New Path For Growth Comes From The Heart
Health

Hims & Hers’ New Path For Growth Comes From The Heart

July 31, 2023No Comments11 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Hims & Hers’ New Path For Growth Comes From The Heart
Share
Facebook Twitter LinkedIn Pinterest Email

The trajectory of well-known health and wellness platform Hims & Hers is one that most entrepreneurs and investors would hope for. Not even six years old, the company has for the most part experienced hockey-stick customer and revenue growth since its inception by offering consumers telehealth-based access to care for historically stigmatized conditions like sexual health and hair loss. With its catchy advertising, relatable brand messaging and prolific marketing machine, hundreds of thousands of consumers were flocking to the marketplace platform by early 2020, eschewing the traditional ways that people access health services.

Then the pandemic happened, and the virtual care market exploded with startups and competitors quickly flooding onto the scene. While Hims & Hers wasn’t operating alone in its market before Covid-19, the venture dollars pouring into the sector meant that pathways to growth and differentiation for its core business would become more challenging. However, Hims & Hers forged on, responding by launching multiple new services lines in 2020 within months of each other, including primary care and mental health.

Despite the emerging competition from well-capitalized peers, the company continued to grow, ultimately riding the pandemic-fueled digital-health wave to a $1.6 billion IPO in January 2021 via a merger with a special purpose acquisition company (SPAC).

But then the brand encountered some brisk headwinds – both from difficulties of the digital-to-consumer (DTC) healthcare sector itself and from general investor hesitation around companies that took the SPAC route. The market became more crowded for all of its offerings, and the company’s customer acquisition costs continued to be high. By Q1 2022, Hims & Hers was still reporting solid revenue growth, but that growth was expensive, with marketing accounting for ~50% of its total revenue, which in part contributed to its share price dipping below $4. Hims & Hers wasn’t the only one taking a hit at the time, as pretty much every public digital health company (and the broader tech market) was experiencing a beating, but its stock did see a precipitous drop from its post-IPO high.

See also  Cell Therapy Prevents Risk Of Heart Attack or Stroke: Study

However, since those lows, Hims & Hers appears to be doing an about face while the broader market is still mired in recovery pains. Each quarterly earnings has bested expectations with the brand achieving EBITDA profitability in Q4 2022. The share price tripled from its lows for a time before settling just above double as of today. Now the company wants to turn another corner by touching an area it hasn’t before – preventive care – and more specifically preventive cardiovascular health.

Hims & Hers started by treating stigmatized conditions, but is moving into chronic care starting … [+] with cardiovascular health

getty

It’s a timely move because some financial analysts have been calling for meaningful innovation from Hims & Hers. The company can’t expect the same approaches and competitive differentiators to keep driving quarterly subscriber growth that effectively doubles year on year while marketing costs continue to hover around 50% of revenue – even if it maintains its 70-80% gross margins. One can look to consumer entertainment powerhouse Netflix after its perpetual subscriber growth came to a screeching halt, even temporarily retreating.

While Hims & Hers has struck deals with retailers like Walgreens and Target for its growing set of over-the-counter products, subscriptions for access to clinical services, especially for men, still make up the overwhelming bulk of its revenue. Yes, there have been new prescription-based options recently launched, but they don’t seem to represent the dramatic TAM expansion opportunities that Wall Street always expects. So now the company aims to expand by introducing its new approach, Heart Health by Hims.

Getting to the “Heart” of the Matter

Starting with the larger brand of the two the company operates (Hims), Heart Health by Hims is the company’s first answer to one of the most devastating healthcare problems globally, cardiovascular disease (CVD). CVD is the leading killer of people across the globe and is both an incredibly complex problem and a massive market, notably in America. Peer-reviewed research suggests that the U.S. spends more than $300 billion, or 15% of total health expenditures, on managing and treating CVD.

Among men, one in every four deaths can be attributed to the disease, which is why Hims & Hers Co-founder and CEO Andrew Dudum feels his company should be well-positioned to have an impact.

Hims & Hers cofounder and CEO Andrew Dudum

Andrew Dudum

“Cardiovascular disease may be one of our biggest opportunities yet,” said Dudum. “While everyone is trying to solve the problem, what’s most exciting to me is that we can leverage what we’ve been doing over the last six years to attack the issue in an interesting way. We already have tens of thousands of men coming to us every week for one of the more noticeable indicators of cardiovascular disease, which is erectile dysfunction.”

There are plenty of well-known risk factors and symptoms that suggest someone may have an elevated risk of developing CVD, but clinical studies have shown that erectile dysfunction (ED) can be an early indicator. As a result, given Hims’ existing large footprint in sexual health, the company is taking what it calls a “dual-action approach” where providers on the platform can “personalize” treatments that combine sexual health and heart health together. Using information from customer intake forms, Hims engages with ED patients who present with other CVD risk factors to educate them, while also informing their provider on the platform that they could be eligible for treatment.

Heart Health is a new offering of Hims & Hers

Hims & Hers

If the provider determines that treatment is clinically appropriate after a consultation, the patient is prescribed a customized formulation of a treatment, which would include different dosages of ingredients found in common ED medications and statins in one tablet. The idea is that men who are interested in improving their sexual health learn about their CVD risk factors and gain access to a treatment that also has a heart health benefit. And since men on ED medications often have a greater desire to stay adherent, there is the potential to improve adherence to preventive statin therapy, which is notoriously poor. Research published in 2019 from the Journal of the American Heart Association concluded “persistence with and adherence to statin therapy remain low.”

“About 30% of the men that come to our platform are at risk of developing cardiovascular disease. Prevention is key, but those at risk may be asymptomatic for the most part. They look in the mirror and don’t see anything wrong,” said Dudum. “By leveraging our brand and the pipeline of men visiting us, we can proactively help them take preventive measures. There’s a real chance that we can bend the curve on deaths over the next five to 10 years.”

Heart in the Right Place

On its face, Heart Health by Hims represents an interesting approach that makes some business sense. Effectively the brand is taking what it’s good at and offering a value-add benefit that deepens relationships with its customers. Compare that to other digital health brands that often scramble to tack on new services that are not in their core expertise and require different staff and/or clinical protocols. They end up burning millions of dollars in the hopes their customers automatically parlay their interest in one thing to another.

However, Hims & Hers does have to confront some of those issues, even if it’s to a lesser extent. While the first Heart Health by Hims approach does involve sexual health, where hundreds of thousands of men clearly already trust the brand, convincing them to trust it with a heart health issue is not automatic.

In response, Dudum believes that the “thoughtful” and “systematic” way his company has expanded will translate into consumer trust for cardiovascular issues. He also said the company has been working towards this expansion for years by amping up its technology and pharmacy capabilities via the previous Apostrophe acquisition and through investments in “hard infrastructure” that includes affiliate pharmacies in Arizona and Ohio.

“This has been a part of the plan, and we’ve worked hard to demonstrate our clinical excellence and safety. From our incredible in-house medical team and advisory board to our external partners, we have clinical standards that are equal to or even better than traditional brick-and-mortar providers,” said Dudum. “Add in the experience our customers receive – with the speed at which they see providers, the quality of the treatment, the level of communication, and the medication adherence rates we’re seeing – and we feel we’ve earned that right to have their trust.”

One of the external partners Dudum is referring to is the American College of Cardiology (ACC), with which Hims & Hers also announced a strategic collaboration. The company reported that its own clinical protocols that guide the Heart Health by Hims approach were partly based on the ACC’s cardiovascular disease risk estimator. Additionally, the ACC will make its own materials available to the company’s customers as part of the formal agreement.

Dr. Ami Bhatt is the American College of Caridiology Chief Innovation Officer

Ami Bhatt

“We are furthering our mission to transform cardiovascular care and improve heart health for all by potentially reducing the risk of heart disease for an at-risk population. Making people aware of their cardiovascular risk and taking steps to prevent disease through diet, exercise, and medication can change the course of the next several decades for these individuals and their loved ones,” said Dr. Ami Bhatt, American College of Cardiology Chief Innovation Officer. “Engaging people in settings where they may discuss their conditions openly but discreetly will hopefully increase the number of people who make reducing their risk of heart disease a regular habit. “Through this collaboration, we’re reaching people with a known increased risk for cardiovascular disease and offering them guidance and education without waiting for them to make a separate appointment to see their doctor.

Hims & Hers also added a formal partnership with nationwide diagnostics provider Labcorp whereby Heart Health by Hims customers can schedule certain labs. Results from the testing could be incorporated into Hims’ EMR, which the company says helps inform provider judgment when and if they want to make any adjustments to treatment.

A Heart Hopefully Made of Gold

Hims & Hers hopes this new cardiovascular approach will build lasting relationships with customers and will be a competitive differentiator to fuel continued subscriber growth, especially since the cost for access to the combined treatments is only nominally higher than the existing ED support. However, Dudum expressed intent to bring a similar approach to other areas like hair loss, mental health and across the Hers brand. Until then, the combined ED and heart support approach will serve as a nice testing ground to evaluate how consumers respond.

While Hims & Hers doesn’t appear to be accepting insurance in the near future, its cash-pay prices generally rival – or are sometimes below – the out-of-pocket costs for consumers when they combine their copays for both a provider visit and a prescription. And customers know the cost of care upfront, which is more transparent than many parts of healthcare, despite valiant price transparency policy efforts.

On the other end, the company is looking to deepen its relationships with traditional providers. Hims & Hers previously has announced partnerships with some health systems, including Privia, ChristianaCare, and even one with another healthcare disruptor, primary care upstart Carbon Health. These co-referral relationships will be increasingly important as its heart health approach scales, because patients the brand can’t handle should have a place to go – especially for cardiology care.

The bottom line is Hims & Hers was bound to make the leap into some form of preventive care, and apparently did so on its own time rather than rush to launch something. It seems this might be a recurring theme for Dudum as the digital health universe expands. While other players have gone all in on the weight loss category with GLP-1s, he recently provided three reasons why his company wasn’t one of them … yet.

Regardless of the time it took to get here, the approach the company is taking with Heart Health by Hims is still rather bold and will have both a high ceiling and a lot of challenges. However, if the strategy ends up being successful, then the hearts of millions of Americans and its Wall Street investors will be at greater ease.

growth heart Hims path
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

‘Exactly What We Want To See’: US Job Growth Beat Expectations For Second Month In A Row

May 2, 2025

China’s 2 Sessions: Slow Growth Collides With Tech Supremacy

March 18, 2025

160 Inspirational Business Quotes for Motivation, Growth and Success

February 11, 2025

Why India’s Growth Momentum Is Losing Steam

January 28, 2025
Add A Comment

Leave A Reply Cancel Reply

Top Posts

Harry Potter Series Inches Closer as Warner Bros. Looks to Close Deal

April 4, 2023

WGA-AMPTP Move Close to Deal After Third Day of Marathon Talks

September 23, 2023

‘Jeopardy!’ Hosts Ken Jennings & Mayim Bialik ‘Griping’ About $1 Million Per Season Salary, Demanding Pay Increase

April 10, 2023

Biden’s ‘Junk Fees’ Crackdown Is A Distraction From The Real Problems, Experts Say

March 10, 2024
Don't Miss

Trump Announces First Post-Tariff Trade Deal

Business May 8, 2025

President Donald Trump announced Thursday the U.S. has reached a trade agreement with the U.K.,…

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025

Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

May 7, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,110)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,626)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

Ahead Of NATO Summit, Russia Intensifies Attack On Ukraine

July 12, 2023

Elon Musk Hints at ‘Small Monthly Payment’ to Access Twitter/X

September 19, 2023

Bloated Government Indebtedness Seen as Here to Stay

August 26, 2023
Popular Posts

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.